Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility to cancer development

Cancer Genetics and Cytogenetics

Volumn 181, Issue 1, 2008, Pages 20-24

  Alho, I ^a   Clara Bicho, M ^a   Carvalho, R ^a   da Silva, A P ^a   Costa, L ^a   Bicho, M ^a  

^a Lisbon Medical School   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE 1; ISOENZYME; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SPREADING; CHROMOSOME 2; CONTROLLED STUDY; CYTOSKELETON; DNA POLYMORPHISM; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOLECULAR WEIGHT; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS;

EID: 38849192543     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.11.004     Document Type: Article

References (23)

1. Malentacchi F., Marzocchini R., Gelmini S., Orlando C., Serio M., Ramponi G., and Raugei G. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers. Biochem Biophys Res Commun 334 (2005) 875-883
2. Raugei G., Ramponi G., and Chiarugi P. Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol Life Sci 59 (2002) 941-949
3. Stoker A.W. Protein tyrosine phosphatases and signalling. J Endocrinol 185 (2005) 19-33
4. Bottini E., Gloria-Bottini F., and Borgiani P. ACP1 and human adaptability: 1. Association with common diseases: a case-control study. Hum Genet 96 (1995) 629-637
5. *B allele. J Biol Chem 266 (1991) 20619-20625
6. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
7. Amorim A., Rocha J., and Santos M.T. Distribution of ACP1, AK1 and ALAD polymorphisms in northern Portugal. Gene Geogr 8 (1994) 147-150
8. Chiarugi P., Taddei M.L., Schiavone N., Papucci L., Giannoni E., Fiaschi T., Capaccioli S., Raugei G., and Ramponi G. LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 23 (2004) 3905-3914
9. Chiarugi P., and Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 28 (2003) 509-514
10. r phosphotyrosine protein phosphatase. FEBS Lett 372 (1995) 49-53
11. Kikawa K.D., Vidale D.R., Van Etten R.L., and Kinch M.S. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J Biol Chem 277 (2002) 39274-39279
12. Taddei M.L., Chiarugi P., Cirri P., Buricchi F., Fiaschi T., Giannoni E., Talini D., Cozzi G., Formigli L., Raugei G., and Ramponi G. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res 62 (2002) 6489-6499
13. Ek P., Pettersson G., Ek B., Gong F., Li J.P., and Zetterqvist O. Identification and characterization of a mammalian 14-kDa phosphohistidine phosphatase. Eur J Biochem 269 (2002) 5016-5023
14. Clerici M., Shearer G.M., and Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst 90 (1998) 261-263
15. Lucey D.R., Clerici M., and Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9 (1996) 532-562
16. Bottini N., Gloria-Bottini F., Amante A., Saccucci P., and Bottini E. Genetic polymorphism and Th1/Th2 orientation. Int Arch Allergy Immunol 138 (2005) 328-333
17. Bottini N., Ammendola M., and Gloria-Bottini F. ACP1 is associated with allergy. Allergy 57 (2002) 651-652
18. Clerici M., Merola M., Ferrario E., Trabattoni D., Villa M.L., Stefanon B., Venzon D.J., Shearer G.M., De Palo G., and Clerici E. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89 (1997) 245-250
19. Bottini N., Stefanini L., Williams S., Alonso A., Jascur T., Abraham R.T., Couture C., and Mustelin T. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 277 (2002) 24220-24224
20. Giannoni E., Chiarugi P., Cozzi G., Magnelli L., Taddei M.L., Fiaschi T., Buricchi F., Raugei G., and Ramponi G. Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity. J Biol Chem 278 (2003) 36763-36776
21. Marraccini P., Iantomasi T., Rigacci S., Pacini S., Ruggiero M., Vincenzini M.T., and Ramponi G. Effect of phosphotyrosine phosphatase over-expression on glutathione metabolism in normal and oncogene-transformed cells. FEBS Lett 344 (1994) 157-160
22. Iantomasi T., Favilli F., Catarzi S., Giannoni E., Biagioni C., and Vincenzini M.T. Involvement of the tyrosine phosphorylation on GSH transport in NIH3T3 fibroblasts. IUBMB Life 55 (2003) 159-165
23. Taddei M.L., Chiarugi P., Cuevas C., Ramponi G., and Raugei G. Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin. Int J Cancer 118 (2006) 2082-2088